Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris.
A. R. Ahmed(Nirma University), Edmond J. Yunis(Dana-Farber Cancer Institute), Khalil A. Khatri(Laser and Skin Surgery Center of New York), Z Awdeh(Harvard University), Chester A. Alper(Harvard University), Richard Wagner(Centre National de la Recherche Scientifique), G Notani(Harvard University)
Cited by 170
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin
|New England Journal of Medicine|2006|452
Genetic Prediction of Nonresponse to Hepatitis B Vaccine
|New England Journal of Medicine|1989|403
IL-10–producing T cells suppress immune responses in anergic tuberculosis patients
|Journal of Clinical Investigation|2000|401
Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.
|Proceedings of the National Academy of Sciences|1995|249